Welcome to the web pages of Phenex !

Phenex is an innovative drug discovery company focusing on the important drug target class of Nuclear Receptors. The company has assembled a powerful drug discovery toolbox for research on this specific target class.

Phenex offers its capabilities on a fee-for-service basis to the biopharmaceutical industry under its Discovery Services unit. Moreover, Phenex pursues three drug discovery programs with the aim to provide new drug candidates for applications in metabolic diseases.

 

Further information on our Discovery Service Offering:

NR Screening Services
large collection of cellular and biochemical NR assays.

NR Selectivity Screening
pre-defined panels for target selectivity checks

SNuRM® Profiling
Classification of compounds according to their Cofactor
recruitment and selective gene induction capabilities.

Latest News / Events

New press release,
09.05.2007


Upcoming Conferences:

August, 27 - 31, 2008
Nuclear Receptors: Bench to Bedside,
Cold Spring Harbor Laboratory